Corona Remedies IPO, Dec. 4 -- Corona Remedies's initial public offering (IPO) is set to open next week for the stock market investors, starting from Monday, 8 December 2025, as the pharmaceutical company aims to raise up to Rs.655.37 crore from the Indian stock market.

The Gujarat-based company is a pharmaceutical company that develops and manufactures products focusing on women's healthcare, cardio-diabetes, pain management, urology, and other therapeutic areas. Corona Remedies has two manufacturing facilities located in Gujarat and Himachal Pradesh.

As of Thursday, 4 December 2025, the grey market premium (GMP) of the Corona Remedies IPO stood at Rs.307 per share. With the upper price band of the public issue at Rs.1,062 apiece, the ...